Electrical Nerve Stimulators | CMS Coverage Update

Summary: The Centers for Medicare & Medicaid Services modified its electrical nerve stimulators coverage policy, effective May 15, 2026. Here's what billing teams need to do.

CMS electrical nerve stimulator coverage policy changes affect a broad range of specialties—pain management, neurology, physical medicine, and orthopedics among them. This modification updates coverage criteria and medical necessity requirements that govern when Medicare will reimburse for electrical nerve stimulation devices and services. The policy document does not list specific CPT or HCPCS codes, so your billing team should cross-reference your current charge capture against the updated criteria directly from the CMS source before the May 15, 2026 effective date.

CMS Electrical Nerve Stimulator Coverage Criteria and Medical Necessity Requirements 2026

The CMS electrical nerve stimulator coverage policy has a long and complicated history. Medicare has covered certain types of electrical nerve stimulation for decades, but coverage has always been tightly tied to diagnosis, device type, and clinical indication. This modification signals another tightening of those lines.

Electrical nerve stimulators fall into several distinct clinical categories under Medicare. Transcutaneous electrical nerve stimulation (TENS) devices, spinal cord stimulators (SCS), neuromuscular electrical stimulators (NMES), and percutaneous electrical nerve stimulators each carry different coverage rules. CMS does not treat them as interchangeable, and your billing team shouldn't either.

Medical necessity is the core of every electrical nerve stimulator claim. CMS requires documentation showing that conservative treatment has failed, that the patient's condition is appropriate for the device type billed, and that a treating physician has ordered the device for a covered indication. Missing any one of those elements is how you get a claim denial before the claim is even reviewed for technical accuracy.

Prior authorization requirements vary by device type and Medicare Administrative Contractor jurisdiction. TENS devices for acute pain, for example, have historically been excluded from Medicare coverage entirely—only TENS for chronic pain in specific diagnoses has been covered under a National Coverage Determination. Spinal cord stimulators require more extensive documentation, including trial period results and psychological evaluation records. Know which device type you're billing before you touch the claim.

The real issue with CMS electrical nerve stimulator billing guidelines is that MAC-level local coverage determinations often layer on top of national policy. Your MAC may have an LCD that is more restrictive than the national rule—and in a conflict, the stricter standard applies. Check both the national policy and your MAC's LCD before May 15, 2026.

CMS Electrical Nerve Stimulator Exclusions and Non-Covered Indications

Not every use of electrical nerve stimulation is a covered benefit under Medicare. Several categories consistently draw non-covered or experimental designations, and the 2026 modification is likely to maintain or tighten these exclusions.

TENS devices for acute pain have no Medicare coverage under the national policy. CMS determined years ago that the evidence for TENS in acute pain does not meet its standard for reasonable and necessary care. Billing TENS for a post-operative acute pain indication on a Medicare patient will produce a denial—not a reimbursement.

Electrical nerve stimulators used primarily for muscle reeducation in patients who are not working toward functional improvement also draw scrutiny. CMS requires documented, measurable progress toward a functional goal for NMES coverage to continue. When that progress plateaus, coverage stops. Your billing team should flag claims where functional documentation is thin or absent.

Investigational uses of high-frequency spinal cord stimulation, dorsal root ganglion stimulation, and closed-loop stimulation systems occupy a gray zone. Some MACs have issued LCDs covering specific high-frequency SCS indications. Others have not. If you're billing for any newer stimulation technology, check your MAC's position explicitly. If you're not sure, loop in your compliance officer before the effective date.

Coverage Indications at a Glance

The policy document available at the time of this writing does not provide a granular indication-by-indication breakdown with specific codes. The table below reflects established CMS coverage positions on electrical nerve stimulator types based on long-standing national coverage determinations. Confirm each row against the updated May 15, 2026 policy text before using this as a billing reference.

CMS Electrical Nerve Stimulator Billing Guidelines and Action Items 2026

CPT, HCPCS, and ICD-10 Codes for Electrical Nerve Stimulators Under This Policy

The policy document does not list specific CPT, HCPCS, or ICD-10 codes. Do not use the list below as a complete billing reference—use it as a starting framework and verify each code against the full updated policy text and your MAC's LCD before the May 15, 2026 effective date.

Commonly Billed HCPCS Codes for Electrical Nerve Stimulators (Verify Against Policy)

These codes are not sourced from the policy document itself. The policy does not list specific codes. Treat this list as a starting point for your internal review only.

A Note on CPT Codes

Implantation, revision, and removal of spinal cord stimulators are billed under CPT codes in the 63650–63688 range. Physician programming and analysis of implanted neurostimulators use CPT codes in the 95970–95982 range. Again—the policy document does not specify these codes. Confirm applicability with the full policy text and your MAC before May 15, 2026.

If you're billing durable medical equipment (DME) for externally worn TENS units, those claims route through your DME MAC, not your Part B MAC. The billing guidelines and coverage criteria may differ.